Clinical trial
Study Evaluating Venlafaxine ER in Adults With Panic Disorder
NCT00038896 · Wyeth is now a wholly owned subsidiary of Pfizer, Industry · Completed
Key facts
| NCT number | NCT00038896 |
|---|---|
| Title | Study Evaluating Venlafaxine ER in Adults With Panic Disorder |
| Official title | A Double-blind, Placebo-controlled, Parallel-group, Flexible-dose Study of Venlafaxine Extended-release Capsules in Adult Outpatients With Panic Disorder |
| Lead sponsor | Wyeth is now a wholly owned subsidiary of Pfizer, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Panic Disorder |
| Intervention type | Drug |
| Interventions | Venlafaxine ER |
| Enrollment | 343 |
| Start date | Apr 1, 2001 |
| Primary completion | Dec 1, 2002 |
| Completion | Dec 1, 2002 |
| First posted | Jun 7, 2002 |
| Last update posted | Aug 14, 2009 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: